Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
2 clusters · 5 sources · 2 days · First seen · Last updated
Medical treatments for retinopathy of prematurity
Overview
Medical developments and clinical interventions regarding Retinopathy of Prematurity (ROP) have been reported in Sweden and Spain.
A randomized clinical study in Sweden, known as DROPROP, investigated the use of dexamethasone eye drops to slow the progression of severe eye disease in extremely premature infants. The study found that infants receiving the corticosteroid eye drops had a 20 percent rate of ROP requiring treatment, compared to 38 percent in the placebo group, suggesting a potential non-invasive method to reduce the need for more destructive procedures.
In a separate clinical case in Spain, specialists at the Hospital General Universitario de Elche utilized a minimally invasive intraocular technique to administer an anti-VEGF biological drug to a newborn born at 24 weeks gestation. The procedure, conducted in collaboration with a Neonatal Intensive Care Unit, aimed to inhibit abnormal retinal blood vessel growth and prevent permanent vision loss.
Entities
Manuel Baeza · Cristian Fernández · University of Gothenburg · Ann Hellström · Hospital General Universitario de Elche
Timeline
-
26 days ago
[HEALTH] 3 sourcesHospital General Universitario de Elche treats premature infant's retinopathyDoctors at the Hospital General Universitario de Elche successfully treated a 24-week premature infant for retinopathy of prematurity using a minimally invasive anti-VEGF drug to preserve vision.
-
27 days ago
[HEALTH] 2 sourcesUniversity of Gothenburg study finds eye drops may prevent blindness in premature infantsA Swedish clinical study suggests dexamethasone eye drops may reduce the risk of severe retinopathy of prematurity in extremely premature infants by 47 percent, potentially avoiding invasive eye surgeries.
Sources
analytica-world.com · bionity.com · lagacetasalta.com.ar · noticiesdigitals.com · vivelasfallas.es